Biogen
BIIB
#932
Rank
โ‚ฌ20.48 B
Marketcap
140,57ย โ‚ฌ
Share price
1.58%
Change (1 day)
-38.47%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ27.12 Billion

According to Biogen's latest financial reports the company's total assets are โ‚ฌ27.12 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Biogen - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ24.28 B6.09%
2022-12-31โ‚ฌ22.89 B8.57%
2021-12-31โ‚ฌ21.08 B5.34%
2020-12-31โ‚ฌ20.01 B-17.67%
2019-12-31โ‚ฌ24.31 B9.98%
2018-12-31โ‚ฌ22.10 B12.14%
2017-12-31โ‚ฌ19.71 B-9.36%
2016-12-31โ‚ฌ21.74 B21.92%
2015-12-31โ‚ฌ17.83 B51.56%
2014-12-31โ‚ฌ11.76 B37.01%
2013-12-31โ‚ฌ8.59 B12.17%
2012-12-31โ‚ฌ7.65 B9.9%
2011-12-31โ‚ฌ6.96 B14.54%
2010-12-31โ‚ฌ6.08 B1.93%
2009-12-31โ‚ฌ5.96 B-1.58%
2008-12-31โ‚ฌ6.06 B2.63%
2007-12-31โ‚ฌ5.90 B-8.83%
2006-12-31โ‚ฌ6.48 B-8.39%
2005-12-31โ‚ฌ7.07 B4.72%
2004-12-31โ‚ฌ6.75 B-10.49%
2003-12-31โ‚ฌ7.54 B283.12%
2002-12-31โ‚ฌ1.97 B1.11%
2001-12-31โ‚ฌ1.94 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ87.08 B 220.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.24 B 92.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ137.42 B 406.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ210.30 B 675.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ170.83 B 529.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.16 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ133.28 B 391.27%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ10.16 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.76 B-78.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.00 B-77.85%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands